Before being approved for emergency use by WHO, India’s Covid-19 Covaxin vaccine was subject to a lot of skepticism, but has proven effective in practice. Immediately after the Covid-19 pandemic began to spread, Bharat Biotech was one of two Indian …
The US company Ocugen asked the FDA to approve the emergency use of India’s Covaxin vaccine for ages 2-18, after WHO approved this vaccine. The approval request is based on a study of 526 children aged 2-18 who received two …
Covaxin – a vaccine made in India – is currently in clinical trials on humans – Photo: Financerewind The decision will pave the way for the vaccine to be approved in many low-income countries, according to Reuters news agency. In …